DOJ sues Forest for False Claims Act violations
Pharma Compliance Alert, March 4, 2009
Forest Laboratories allegedly improperly marketed its antidepressants Celexa and Lexapro for unapproved pediatric use and paid kickbacks to induce physicians to prescribe the drugs, according to a Department of Justice (DOJ) release.
The company’s illegal promotional practices surrounding Celexa and Lexapro caused thousands of false and fraudulent claims to be submitted to federal healthcare programs, the DOJ alleged.
Read more about the False Claims Act allegaions against Forest.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Medical Environment Update
Timely medical compliance news from OSHA, CDC, EPA, and other regulatory agencies!
-
Bloodborne Pathogens Training Video
Meets OSHA requirements for training employees on the bloodborne pathogens standard!
-
Hazard Communication Standard Training Video
Meets OSHA requirements for training employees on the Hazard Communication Standard!
-
Stark Law, 2nd edition: A user's guide to achieving compliance
This updated version of HCPro's Stark Law best seller, first published in 2005—and now co-authored by former CMS Stark...
Most Popular
- Articles
-
- Note from Hugh
- Jury sides with blood lab technician in New Jersey whistleblower case
- Questions surround when time starts for proposed inpatient presumption
- Q/A: Should we use modifier -Q0 to override edits for ICDs?
- Five tips for an effective hospital patient safety program
- Overnight physicians in ICU show little effect on outcomes
- QAPI is coming: Is your facility preparing for its arrival?
- CMS releases updated MDS 3.0 RAI User's Manual
- Tip: Review codes that are now packaged
- Maine comes in first in hospital safety
- E-mailed
-
- Questions surround when time starts for proposed inpatient presumption
- Jury sides with blood lab technician in New Jersey whistleblower case
- Q/A: Should we use modifier -Q0 to override edits for ICDs?
- Overnight physicians in ICU show little effect on outcomes
- Tip: Review codes that are now packaged
- QAPI is coming: Is your facility preparing for its arrival?
- ACDIS/AHIMA brief provides guidance on query best practices
- Maine comes in first in hospital safety
- Surgical residents disapprove of duty hour restrictions
- Tip: Nursing documentation requirements for observation services
- Searched